Prediction of cardiovascular events in patients with chronic myeloid leukaemia using baseline risk factors and coronary artery calcium scoring-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of cardiovascular events in patients with chronic myeloid leukaemia using baseline risk factors and coronary artery calcium scoring

Published:2021-10 Issue:10 Volume:51 Page:1736-1740
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Baggio Diva¹^ORCID,Tan Sean²,Porch Kylie¹,Shortt Jake¹³,Ko Brian²

Affiliation:

1. Monash Haematology Monash Health Melbourne Victoria Australia

2. Monash Heart Monash Health Melbourne Victoria Australia

3. School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15517

Reference10 articles.

1. Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UKTARGET CML study;Milojkovic D;Br J Haematol,2021

2. General cardiovascular risk profile for use in primary care: the Framingham heart study;D'Agostino RB;Circulation,2008

3. Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors: cardiovascular risk assessment in CML;Ross DM;Intern Med J,2018

4. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis;Erbel R;J Am Coll Cardiol,2010

5. 2017 Cardiovascular and stroke endpoint definitions for clinical trials;Hicks KA;Circulation,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An association between Dasatinib, elevated left atrial pressure and pleural effusion;International Journal of Cardiology;2024-09

2. Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes;Cancer Management and Research;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3